TenSixteen Bio
No bio yet
This person is not in any offices
TenSixteen Bio
TenSixteen Bio is the first company to leverage somatic mosaicism and clonal hematopoiesis of indeterminate potential (CHIP) to discover and develop novel therapeutics to treat age-related diseases.